PERSPECTA

News from every angle

← Back to headlines

Pfizer, Alnylam, BridgeBio Stock Gains After AstraZeneca/Ionis Trial Setback

Pfizer, Alnylam, and BridgeBio shares saw gains following a late-stage trial setback for AstraZeneca and Ionis.

9 Jul, 11:26 — 9 Jul, 11:26
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed30d ago

Pfizer, Alnylam, BridgeBio gain after late-stage trial setback for Astra/ Ionis

Read full article →

Related Stories

Woman Kills Partner with Knife in Croatia

18m ago

Man Arrested for Murder in Petrovac na Mlavi, Serbia

22m ago

Woman Describes Saving Passenger on Ryanair Flight After Head Emerges from Window

24m ago

Death Toll Rises to Seven from Habagat and Storms in Philippines

26m ago